Related Topics
Victor De Gruttola’s storied career celebrated at biostatistics symposium
Members of the Department of Biostatistics recently gathered for a symposium celebrating the 50-year career of Victor De Gruttola, former chair and professor of biostatistics emeritus.

Timing of HIV treatment during pregnancy could affect developmental delays in children
During pregnancy, the timing of when mothers start taking antiretroviral drugs to treat HIV may impact the risk of developmental delays in children, according to a study co-authored by researchers at Harvard Chan School.
Strength in numbers
Octavious Smiley, PhD ’23, is dedicated to helping the next generation of minority students excel in the field of biostatistics.

PEPFAR program marks 20 years, 20 million lives saved
PEPFAR was the largest public health effort by one country against a single disease, and as of late last year, has provided lifesaving treatment to more than 20 million people suffering from HIV/AIDS.
New vaccine platform could aid in fight against deadly viruses
Researchers at Harvard Chan School have developed a new, highly adaptable vaccine platform that could potentially be a powerful tool in the fight against viral pathogens including influenza, HIV, and SARS-CoV-2.

Project uses geographic data to show that where a person lives matters to their health
Harvard Chan School's Nancy Krieger and colleagues have updated and broadened a project aimed at training people in how to track and monitor socially related disparities having to do with where a person lives.

Addressing the wide-ranging health challenges of homelessness
Homelessness leads to a wide range of health challenges and should be tackled through multiple angles, according to Howard Koh.
Dolutegravir-based antiretroviral therapies for HIV-1 effective in pregnancy
For immediate release: September 1, 2022 Boston, MA— Dolutegravir-based antiretroviral therapies (ART) for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in the U.S. and Europe, according to a study led by…

Opinion: Botswana lab that identified omicron is model for global health goals
The first lab to identify the omicron COVID-19 variant, established by the government of Botswana and Harvard Chan School, is a model of a successful global health response, according to an opinion article.

Thirteen students awarded Rose Service Learning Fellowships for winter, spring projects
Over the next few months, students in the latest group of Rose Service Learning Fellows at Harvard T.H. Chan School of Public Health are launching a diverse array of field projects.
